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Abstract
The growing epidemic of obesity and metabolic diseases calls for a better understanding of adipocyte biology. The
regulation of transcription in adipocytes is particularly important, as it is a target for several therapeutic approaches.
Transcriptional outcomes are influenced by both histone modifications and transcription factor binding. Although the
epigenetic states and binding sites of several important transcription factors have been profiled in the mouse 3T3-L1 cell
line, such data are lacking in human adipocytes. In this study, we identified H3K56 acetylation sites in human adipocytes
derived from mesenchymal stem cells. H3K56 is acetylated by CBP and p300, and deacetylated by SIRT1, all are proteins with
important roles in diabetes and insulin signaling. We found that while almost half of the genome shows signs of H3K56
acetylation, the highest level of H3K56 acetylation is associated with transcription factors and proteins in the adipokine
signaling and Type II Diabetes pathways. In order to discover the transcription factors that recruit acetyltransferases and
deacetylases to sites of H3K56 acetylation, we analyzed DNA sequences near H3K56 acetylated regions and found that the
E2F recognition sequence was enriched. Using chromatin immunoprecipitation followed by high-throughput sequencing,
we confirmed that genes bound by E2F4, as well as those by HSF-1 and C/EBPa, have higher than expected levels of H3K56
acetylation, and that the transcription factor binding sites and acetylation sites are often adjacent but rarely overlap. We
also discovered a significant difference between bound targets of C/EBPa in 3T3-L1 and human adipocytes, highlighting the
need to construct species-specific epigenetic and transcription factor binding site maps. This is the first genome-wide
profile of H3K56 acetylation, E2F4, C/EBPa and HSF-1 binding in human adipocytes, and will serve as an important resource
for better understanding adipocyte transcriptional regulation.
Citation: Lo KA, Bauchmann MK, Baumann AP, Donahue CJ, Thiede MA, et al. (2011) Genome-Wide Profiling of H3K56 Acetylation and Transcription Factor
Binding Sites in Human Adipocytes. PLoS ONE 6(6): e19778. doi:10.1371/journal.pone.0019778
Editor: Marc Tjwa, University of Frankfurt-University Hospital Frankfurt, Germany
Received October 14, 2010; Accepted April 15, 2011; Published June 2, 2011
Copyright:  2011 Lo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: K.A.L is supported by the National Science Scholarship from Agency of Science, Technology and Research, Singapore. E.F. is the recipient of the Eugene
Bell Career Development Chair. This work used computing resources funded by the National Science Foundation under Award No. DBI-0821391. This research
was funded by Pfizer Inc., and the co-authors who are Pfizer employees were involved in the study design, data collection and analysis, decision to publish, and
preparation of the manuscript.
Competing Interests: MKB APB MAT LH and SGD are Pfizer Inc. shareholders. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing
data and materials.
* E-mail: fraenkel-admin@mit.edu
Introduction
White adipose tissue is a key organ in the regulation of whole
body energy homeostasis [1]. Besides acting as a passive fat storage
organ, it serves to regulate systemic energy homeostasis by
secreting various soluble mediators, widely termed adipokines,
examples of which include leptin, adiponectin, visfatin and resistin
[2]. It has been recognized that an increase in white adipose tissue
mass is associated with insulin resistance, a major cause of
diabetes, hypertension and cardiovascular diseases. With the
growing epidemic of obesity, a better understanding of adipocyte
biology could potentially lead to novel drug targets to tackle
obesity-related metabolic diseases.
Transcriptional controls have emerged as a particularly
important aspect of cellular regulation that can be exploited for
therapeutic benefit in diabetes. Both the most widely prescribed
anti-diabetic treatment, metformin, as well as the more recently
developed thiazolidinediones act by modulating the activity of
transcriptional regulatory proteins [3,4]. Recent advances in high-
throughput technologies now provide methods for examining
transcriptional regulation across the genome, potentially revealing
key transcriptional regulators that could serve as potential drug
targets. For example, chromatin immunoprecipitation followed by
microarray analysis (ChIP-chip) or next generation massively
parallel sequencing (ChIP-seq) can be used to probe genome-wide
DNA-protein interactions. Currently, most of the ChIP-chip or
ChIP-seq experiments on adipocytes have been done in cell lines
of murine origin such as the preadipocyte cell line 3T3-L1 [5,6,7].
Given that tissue-specific transcription has diverged significantly
between human and mouse [8], there is a need to construct a
human adipocyte transcriptional regulatory network.
Changes in histone acetylation appear to have a central role in
insulin function and insulin resistance. Both insulin and metformin
have been shown to alter the activity of the histone acetyltrans-
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heterozygous mice are lipodystrophic, they are protected from
diet-induced insulin resistance [10]. Furthermore, the histone
deacetylase (HDAC) SIRT1, by virtue of its role in inflammatory
responses, adipokine secretion and its interaction with the insulin
signaling pathway, is suggested to have therapeutic benefit in
treating insulin resistance [11]. Recently, it has been shown that
the lysine 56 of histone H3 (H3K56) is acetylated by CBP and
p300 and deacetylated by SIRT1 and SIRT2 [12]. Given the roles
that HATs and HDACs play in controlling insulin sensitivity, and
that the H3K56 acetylation status is a consequence of the
combined activity of HATs and HDACs, we measured the
genome-wide distribution of H3K56 acetylation in normal human
adipocytes.
The presence of H3K56 acetylation has only been recently
discovered in humans [12], therefore the molecular function and
significance of H3K56 acetylation in humans is less studied than in
yeast. It has been shown that in human embryonic stem cells prior
to differentiation, H3K56 acetylation marks targets of the key
regulators of pluripotency, namely NANOG, SOX2 and OCT4
[13]. Upon cellular differentiation, H3K56 acetylation relocates to
developmental genes.
In this study, we measured sites of H3K56 acetylation across the
genome in mature adipocytes derived from human mesenchymal
stem cells (hMSC) [14], which provide a good in vitro model to
study protein-DNA interaction in human adipocytes and comple-
ment the more widely used mouse cell lines 3T3-L1 and 3T3-
F442A. We showed that in these cells, H3K56 acetylation is
associated with almost half of the genome and it primarily occurs
around transcription start sites. Genes with this modification were
generally associated with higher expression, and genes with the
highest levels of H3K56 acetylation are enriched for transcription
factors, adipokine signaling and diabetes-related proteins. We used
computational methods to identify DNA-binding proteins that
might recruit acetyltransferases and deacetylases to the sites of
H3K56 acetylation. We found a strong enrichment of the E2F
motif in these regions and demonstrated using ChIP-seq that E2F4
binds many of these loci. ChIP-seq analysis also showed that the
majority of HSF-1- and C/EBPa-bound genes are enriched for
H3K56 acetylation. At sites where the H3K56 acetylation
modification and transcription factor binding co-occur, H3K56
acetylation is usually adjacent to but not directly overlapping the
transcription factor binding sites. These data provide the first
genome-wide view of H3K56 acetylation in human adipocytes,
paving the way for future studies aimed at understanding how
epigenomic modifications influence obesity-related diseases.
Results
Differentiation of mature human adipocytes
Since we are interested in studying transcriptional regulation in
human adipocytes, we derived mature adipocytes from human
bone marrow mesenchymal stem cells purchased from Lonza.
Differentiation took 19 days, including 14 days in adipogenic
differentiation media and 5 days in adipogenic maintenance media
(see Methods for details). Figure 1A shows that before differen-
tiation, cells exhibit an elongated and fibroblast-like morphology.
After differentiation, cells become more round and accumulate
multiple intracellular lipid droplets. Using the Cellomics high
content imaging system, we determined the differentiation
efficiency of replicate samples of 6 independent differentiation
experiments (Table S1) with cells from different passages (only cells
less than passage 8 were used). We estimated that the
differentiation efficiency was 61% 64 %, as determined by the
number of cells that have intracellular lipid droplets (stained by
Nile red) over the total number of nuclei observed (stained by
DAPI). Cellomics data also show that about 54% of the cells were
positive for the adipocyte marker, PPARc, and that the PPARc
staining largely overlaps with that of DAPI (Figure 1B), as
expected for mature adipocytes. We developed a purification
process to separate mature adipocytes, which are buoyant during
centrifugation, from immature adipocytes, which pellet. Based on
visual examination under the microscope, our adipocyte prepara-
tion appears to be at least 90% mature adipocytes.
Overall analysis of H3K56 acetylation sites
After crosslinking the mature adipocytes using formaldehyde
which captures in vivo protein-DNA interactions, we performed
chromatin immunoprecipitation with an antibody that specifically
targets the acetylated lysine 56 of histone 3. The specificity of the
antibody for this particular histone acetylation site has been
previously shown in ChIP experiments and other applications
[12,15,16]. Immunoprecipitated protein-DNA complexes were
reverse-crosslinked, purified DNA was sequenced using the
Illumina Genome Analyzer II, and the resulting sequences were
used to identify enriched regions as described in Materials and
Methods. A gene was considered to have H3K56 acetylation if
there was at least one ChIP-seq peak within 10 kilobases of the
transcription start site. The 10-kilobase window was chosen in
light of a recent report showing that a regulatory site’s influence on
expression falls off almost linearly with distance from the nearest
transcription start site in a 10-kilobase range [17]. The number of
reads, peaks and genes bound/enriched for each ChIP-seq
experiment performed is listed in Table S3.
Using these criteria, we found that 10,215 genes have H3K56
acetylation. While the majority of the H3K56 acetylation sites
occur at the proximal promoter region (Figure 2A), there is a drop
in H3K56 acetylation right before transcription start sites (Figure
S1). The same observation has been made on genome-wide data
for other histone modifications such as H3K4me2 and H3K4me3
in hematopoietic cells [18]. These findings suggest that there is a
depletion of nucleosomes immediately upstream to transcription
start sites.
Genes enriched for H3K56 acetylation are also targets of
three different transcription factors
In order to discover the DNA-binding proteins that recruit
acetyltransferases and deacetylases to sites of H3K56 acetylation,
we searched for the DNA sequence motif associated with the
H3K56 acetylation-enriched regions using the THEME algorithm
[19]. The top motif obtained was that of E2F (Figure 2B),
suggesting that members of this family of proteins might bind to
these loci. To verify this, we performed ChIP-seq on the cell cycle
regulator E2F4. E2F4 was found to bind to 5,340 genes, of which a
very high proportion (87%) was also enriched for H3K56
acetylation. We not only found that H3K56 acetylation and
E2F4 binding occur at a similar set of genes, we also found that the
acetylated and binding locations are usually close to each other,
with 74% of E2F4 binding sites occurring within 300 base pairs of
an H3K56 acetylation site (Table S4). The genomic distribution of
E2F4 was highly similar to that of H3K56 acetylation (Figure 2A),
with the majority of the sites proximal to transcription start sites.
The frequent association of E2F4 binding and H3K56 acetylation
supports the hypothesis that E2F4 recruits HATs and HDACs to
these sites.
HATs and HDACs also modify DNA binding proteins in
addition to acetylating and deacetylating histones respectively. It is
interesting that three of the proteins known to alter acetylation of
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acetylate and deacetylate the master regulator of heat shock
response, HSF-1, affecting its DNA binding activity and
expression of its target genes [20]. In order to determine if HSF-
1 and H3K56 acetylation share similar target genes, we performed
ChIP-seq on HSF-1. Our genome-wide HSF-1 data show that in
mature human adipocytes, HSF-1 binds to 174 genes, 90% are
also enriched with H3K56 acetylation and 69% of the peaks
associated with HSF-1-bound genes are within 300 base pairs of
an H3K56 acetylation site.
E2F4 and HSF-1 are ubiquitously expressed transcription
factors, whose functions appear to be conserved across many
tissues, raising the question as to whether H3K56 acetylation
might also be associated with the binding of adipocyte-specific
proteins. To explore this question, we profiled the genome-wide
binding sites of the master regulator of adipocytes, C/EBPa.
C/EBPa binds to 5,818 genes, of which 74% also have an H3K56
acetylation mark. The complete list of genes that have H3K56
acetylation and are also bound by at least one transcription factor
is listed in Table S5.
In order to verify the acetylation and transcription factor
binding sites identified by the above four ChIP-seq experiments,
we selected 21 positive regions and 2 negative regions to perform
independent ChIP-qPCR experiments (Figure S2) in biological
triplicates. We found that among the 21 positive loci tested, 20
show significant enrichment when compared to the IgG control.
The 2 negative control regions show no enrichment in all the
ChIP-qPCR experiments performed.
When we examined the percent of overlap between H3K56
acetylation sites and the binding sites of the different transcription
factors, we noticed that while HSF-1 and E2F4 are very often
recruited to regions where H3K56 acetylation occurs, this is not as
common for C/EBPa: only 31% of the peaks associated with the
C/EBPa-bound genes are within 300 base pairs of an H3K56
acetylation site. Furthermore, in contrast to the enriched regions of
E2F4 and H3K56 acetylation, C/EBPa-enriched regions have a
more dispersed distribution throughout the 10-kilobase window
around transcription start sites (Figure 2A), and a large proportion
of C/EBPa peaks (79%) lies beyond 10 kilobases from transcrip-
tion start sites. The more widespread distribution of C/EBPa
binding sites agrees with the study by Lefterova et al [6]. When we
compared our C/EBPa data set with a recently published PPARc
ChIP-seq data set in human adipose stromal cells derived
adipocytes [21] , 43% of the C/EBPa-enriched regions (14,174
out of 32,864) overlapped with the PPARc-enriched regions, while
a previous study comparing C/EBPa and PPARc ChIP-chip data
in 3T3-L1 [6] using promoter arrays shows that the two factors
share 63% of their binding sites. The lower percentage of overlap
Figure 1. Images of bone marrow mesenchymal stem cells before and after adipogenic differentaion. (A) The left panel shows 4x phase
contrast microscope images of undifferentiated human bone marrow mesenchymal stem cells and the right panel shows the differentiated
adipocytes at day 19. (B) Cellomics image analysis of the human bone marrow mesenchymal stem cells-derived adipocytes after 19 days of
differentiation, fixed and stained with DAPI (nuclei-blue), Nile red (a selective fluorescent stain for intracellular lipid droplets-yellow), and specific
antibodies for PPARc (Alexa 647-magenta). The left panel shows the lipid and nuclei staining and the right panel has additional PPARc staining, three
of which are indicated with red arrows.
doi:10.1371/journal.pone.0019778.g001
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are comparing C/EBPa and PPARc binding sites in two different
human adipocyte systems; it could also be because the ChIP-seq
technology recovers many more distal binding sites.
Bound genes are associated with higher expression
Histone acetylation is generally found to be associated with gene
activation, while particular DNA-binding proteins can either
activate or repress transcription. We compared our data to gene
expression data from mature human adipocytes (Des Etages, S. et
al. manuscript in preparation) and found that genes with H3K56
acetylation are associated with higher expression (Figure 3A).
However, similar to what has been observed in human embryonic
stem cells [13], H3K56 acetylation marks are not restricted to
highly expressed genes; some unexpressed or poorly-expressed
genes also harbor this modification, suggesting that H3K56
acetylation is not simply a marker for gene activity. We divided
genes that have H3K56 acetylation based on the distance from
their transcription start sites to the nearest acetylation site. We
found that genes with one or more H3K56 acetylation sites within
2 kilobases of transcription start sites have significantly higher level
of expression compared to the unmodified genes or genes with the
modification further away from transcription start sites (p-
value,1e-15; Figure 3B). Similarly, genes that are bound by
E2F4, HSF-1 or C/EBPa are also associated with higher
expression (Figure 3A). The differences of the expression
Figure 2. Genome-wide analysis of H3K56 acetylation and transcription factor binding in human adipocytes. (A) Histograms showing
that the distributions of peaks for all four ChIP-seq experiments are centered on transcription start sites; the X-axis represents distance from
transcription start sites and the Y-axis represents frequency. H3K56ac is H3K56 acetylation (B) Sequence motifs associated with the enriched regions
in each ChIP-seq experiment. Only the highest ranked motif is shown. Cross-validation errors (‘‘CV error’’) and p-values were calculated as described in
Methods.
doi:10.1371/journal.pone.0019778.g002
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transcription factors under study are highly significant (p-
value,1e-15).
Many genes for adipocyte transcription factors are highly
acetylated at H3K56
Our genome-wide H3K56 acetylation data reveal that a
surprisingly large number of genes (10,215) are enriched for this
histone modification. We hypothesized that genes with very high
levels of acetylation might be functionally distinct from those with
lower levels of acetylation. Indeed, when we ranked the genes with
H3K56 acetylation by the number of acetylated sites per gene, we
found that 47 of the top 161 genes (all of which have five or more
H3K56 acetylation sites) are annotated as transcription factors, (p-
value: 3.5e-11) and twelve of them are from the homeobox
structural class (EMX2, HOXA10, HOXA9, HOXB2, HOXC9,
IRX5, LMO4, MEIS1, MEIS2, PRRX1, SATB2 and SIX2; p-
value: 4.8e-7). Many homeobox transcription factors are involved
in the control of gene expression during morphogenesis and
development, and some of them have been shown to have
important roles in the differentiation of adipocytes [22]. This
observation is in agreement with the observation that develop-
mental genes are hyperacetylated at H3K56 in differentiated cells
[13]. Other important adipocyte-related transcription factor genes
that are hyperacetylated include CEBPA, CEBPB, CEBPD,
KLF6, KLF9, FOXC1, IRF1, PPARA, RXRA and THRA
(Figure 4A).
To search more systematically for classes of genes with high
levels of H3K56 acetylation, we ranked the 10,215 genes with
H3K56 acetylation by the number of H3K56 acetylation sites per
gene. Gene set enrichment analysis [23] identified a number of
gene sets that were overrepresented at the top of this list, including
the KEGG adipokine signaling pathway and the KEGG type II
Diabetes Mellitus (T2DM) pathway (Figure 4B). Thus, high levels
of H3K56 acetylation may be associated with regulation of
adipokine secretion and the etiology of T2DM. All the gene sets
that have a family-wise error rate (FWER) of less than 0.05 are
listed in Table S7.
C/EBPa-bound targets are enriched for lipid metabolic
genes and adipokines
The genome-wide binding data of C/EBPa recovered many
known regulatory sites on genes that are important in adipogenesis
and adipocyte function, including FABP4/aP2, a fatty acid
binding protein; CD36, a regulator of fatty acid transport;
LIPE/HSL, an enzyme that regulates hormone-mediated lipolysis;
OLR1, a low density lipoprotein receptor, and ME1, an enzyme
that generates NADPH for fatty acid biosynthesis. The top gene
ontology (GO) category that is associated with the C/EBPa-bound
genes is lipid, fatty acid and steroid metabolism (p-value: 4.3e-4,
Table S8). As previously reported, C/EBPa regulates transcription
of the human adiponectin gene through an intronic enhancer [24].
We were able to confirm the existence of such an enhancer in our
model of hMSC-derived adipocytes (Figure S3). In addition, we
also observed C/EBPa binding sites on the resistin promoter and
retinol-binding protein 4 (RBP4) promoter, suggesting that C/
EBPa may have a role in mediating the expression of adipokines.
The human C/EBPa gene is almost 90% homologous to its rat
and mouse counterparts [25]. Because of this high degree of
homology, we asked if the majority of the human C/EBPa-bound
genes are also bound in mouse. To determine the degree of
conservation of C/EBPa binding between human and mouse
adipocytes, we compared our C/EBPa ChIP-seq data with the
published C/EBPa ChIP-chip data in 3T3-L1 [6]. There are
3,998 C/EBPa-bound genes in 3T3-L1, out of which 3,345 have
human orthologues. We found that 48% (1,636 out of 3,345) of the
C/EBPa targets in 3T3-L1 are also targets in human adipocytes.
Most (72%, 4,182 out of 5,818) of the human adipocyte C/EBPa
target genes are unique. Some of the differences between these
data sets are undoubtedly due to the fact that they were collected
with different experimental techniques. However, the data are also
consistent with the observations that binding sites have diverged
significantly between human and mouse for several other highly
conserved transcription factors [8].
HSF-1 binds to classic heat shock protein genes in
unstimulated human adipocytes
HSF-1 is a transcription factor induced by diverse environmen-
tal and physical stresses. Our experiment provides the first
comprehensive view about the role of HSF-1 in human adipocytes.
The genome-wide HSF-1 data show that in mature adipocytes,
HSF-1 binds to 174 genes, examples of which are DNAJB6,
HSPH1, HSPA9, HSPD1, HSPB1, CCT4 and CCT7; many of
the bound genes are involved in protein folding (p-value: 8.4e-17),
protein metabolism and modification (p-value: 2.2e-8), protein
complex assembly (p-value: 2.9e-5) and stress response (p-value:
2.8e-4) (Table S8). This finding highlights the fact that even in
unstimulated and unstressed adipocytes, HSF-1 binds DNA. This
is the first time that HSF-1 binding sites have been profiled in
human adipocytes. It will be interesting to compare HSF-1
binding sites in other quiescent tissues under non-heat shock
conditions.
E2F4 targets in human adipocyte are highly enriched for
cell cycle genes
We found that in human adipocytes, E2F4 binds to many genes
(5,340) that have not previously been recognized as its targets; the
majority of the binding sites are located proximal to transcription
start sites: 83.5% and 61.9% are located less than 1000 and 100
bases from transcription start sites, respectively. The top GO
categories associated with the E2F4-bound genes are DNA
metabolism (p-value: 5.1e-14), cell cycle (p-value: 1.1e-15) and
chromatin packaging and remodeling (p-value: 5.0e-9) (Table S8).
True to its role as a cell cycle regulator, E2F4 binds to many of the
well-known cyclin-dependent kinases (CDK2, CDK4, CDK5) and
cyclin-dependent kinase inhibitors (CDKN1A, CDKN1B,
CDKN1C, CDKN2A, CDKN2C, CDKN2D and CDKN3) in
human adipocytes.
In order to assess the differences in binding among different
human tissues, we compared our E2F4 ChIP-seq data in
Figure 3. Genes that are bound by transcription factor or acetylated at H3K56 are associated with higher expression. (A) Comparison
of the expression level of all genes (left panel) to genes that have (red) or do not have (blue) H3K56 acetylation or transcription factor binding sites.
The dark band in the middle of the each box represents the median expression value of all gene that have/do not have an H3K56 acetylation or
transcription factor binding sites. Asterisks represent statistical significance with p-values,1e-16. (B) The top panel shows the distribution of
expression values for genes that have been categorized based on the distance from their transcription start sites to the nearest H3K56 acetylation
peak. The number within each box represents the number of genes in each category. The bottom panel is similar to the top one, zooming in around -
1000 to +1000 base pair window.
doi:10.1371/journal.pone.0019778.g003
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liver, pancreatic islets, pancreatic acinar tissues and the liver
carcinoma cell line HepG2 [26]. Using promoter arrays capturing
up to 1 kilobase immediately upstream of most transcription start
sites, Conboy et al. found that there are 441 genes common among
the four human tissues/cell types. We found that among these 441
genes, almost half (195 genes) were bound by E2F4 in adipocytes.
A large proportion of the common genes were related to the cell
cycle process (60 out of 199, p-value: 5.02e-14), in accord with the
previous finding that cell cycle genes are the conserved targets of
E2F4 [26].
Transcription factor binding sites and H3K56 acetylation
marks are often adjacent but do not overlap
Comparing the genome-wide H3K56 acetylation distribution
with the binding sites of C/EBPa, HSF-1 and E2F4, we found that
the majority of the genes that are bound by each protein are also
acetylated at H3K56 (p-value,1e-15, Table S4). The fraction of
the transcription factor binding sites that is within 300 base pairs of
a site of acetylation ranges from 31% to 74%. Despite the
proximity of these sites, we found that transcription factor binding
sites rarely occur at exactly the same location as the strongest sites
of acetylation. An example is illustrated by the DUSP1 gene,
which has multiple H3K56 acetylation sites at the promoter and
gene body (Figure 5A). It also has C/EBPa, E2F4 and HSF-1
binding sites within 2 kilobases from the promoter. Figure 5A
shows that C/EBPa and HSF-1 bind at the same genomic
location, and E2F4 binds closer to the transcription start site.
However, none of the binding sites of the above three transcription
factors overlap with the H3K56 acetylation regions. On the
genome-wide level, we examined genes that have H3K56
acetylation as well as E2F4 and C/EBPa binding sites within
1500 base pairs of each other (we excluded the HSF-1 data as
HSF-1 only binds to less than 200 genes genome-wide). For each
region, we computed the pairwise correlation coefficient of
binding location between transcription factors and between each
transcription factor and H3K56 acetylation (see Methods). E2F4
and C/EBPa binding locations often show positive correlation,
and a significant number even have a perfect correlation with
r=1, suggesting that the binding sites directly overlap one
another. On the other hand, E2F4 and H3K56 acetylation rarely
exhibit perfect correlation and they are often negatively correlated
(Figure 5B). We display the ChIP-seq enrichment signal across
1500 base pairs, center around the strongest E2F4 peak in a
heatmap format (Figure 5C). The heatmap clearly illustrates that
binding of E2F4 and C/EBPa often occur at identical genomic
loci, but this is not the case for E2F4 and H3K56 acetylation.
Discussion
The binding of transcription factors and the modification of
histones are highly interdependent processes that together
determine the epigenetic state of the cell and regulate gene
expression. A more thorough enumeration of genome-wide
transcription factor binding sites and histone modifications,
combined with gene expression analysis, could lead to a better
understanding of how gene regulation occurs. This systems
approach could be of great use in identifying better mechanisms
for manipulating transcription for therapeutic purposes.
We have presented the genome-wide locations for the
acetylation of H3K56, a histone modification regulated by CBP,
p300 and SIRT1, all of which have been implicated in insulin
resistance. To better understand the mechanism by which these
histone modifying enzymes are recruited to these loci, we used
sequence analysis to discover motifs that are overrepresented near
sites of H3K56 acetylation. We observed enrichment for the
binding sequence for E2F proteins and used ChIP-seq to confirm a
dramatic enrichment of E2F4 bound genes at H3K56 acetylation
regions. Surprisingly, we found that the binding sites of two other
transcription factors, HSF-1 and C/EBPa, also show a significant
degree of overlap with the sites of H3K56 acetylation (Table S4).
Approximately 70% of the binding sites for each of HSF-1 and
E2F4 and approximately 30% of the C/EBPa sites are within
three hundred bases of a site of H3K56 acetylation. The very high
frequency of H3K56 acetylation near HSF-1 and E2F4 raises the
interesting possibility that these two proteins may recruit the
acetylase(s) that modifies H3K56. It is interesting that transcription
factor binding and H3K56 acetylation generally do not occur at
the exact same genomic location. This probably reflects the fact
that the transcription factors we have examined cannot bind to
DNA that is wrapped around the histone core. In contrast, E2F4
and C/EBPa can be found in much closer proximity to each
other.
Genes that are bound by one or more factors or harbor the
particular H3K56 acetylation modification are associated with
higher expression levels, reflecting the general role of these
transcription factors and histone modification in gene activation.
Although H3K56 acetylation is widespread in human adipocytes,
the genes that have the highest levels of acetylation are enriched
for particular functions, including transcriptional regulation and
adipokines and diabetes-related pathways. Many of the transcrip-
tion factors with high levels of H3K56 acetylation have not been
associated with adipocytes before. It is worth investigating the role
of these transcription factors in adipocyte function.
Mikkelsen et al. recently profiled the genome-wide binding sites
of PPARc, CTCF and six histone modifications, namely
H3K4me1, H3K4me2, H3K4me3, H3K27me3, H3K27ac and
H3K36me3 in human adipose stromal cells (hASCs) derived from
adult subcutaneous lipoaspirates [21]. We noticed that our H3K56
acetylation profile closely mirrors the open chromatin marks
H3K4me2 and H3K27ac that they profiled, with 90% and 87%
overlap, respectively. H3K56 acetylation has the least overlap (8%)
with H3K27me3, which represents polycomb-mediated repres-
sion. Interestingly, the overlap of H3K56 acetylation with
promoter initiation mark H3K4me3 is a moderate 55%, implying
that H3K56 acetylation is more of an open chromatin mark rather
than a transcription initiation mark.
Regarding the physiological role of H3K56 acetylation, recent
work in Sirt6 knock-out mice reveals the association between
hyperacetylation of H3K56 and obesity [16]: neural specific Sirt6-
deleted mice have adult-onset obesity, and they show hyperace-
tylation at H3K9 and H3K56 in various brain regions [16]. The
extent of H3K56 hyperacetylation is particularly widespread; it
was observed in whole cell extracts from hypothalamus, cortex,
Figure 4. Genomic maps of examples of H3K56 acetylation-enriched genes. (A) H3K56 acetylation modifications were found on the
promoters and gene body of C/EBPa, C/EBPb and C/EBPd. Background represents the mock IgG experiment reads. Rectangular boxes below the
H3K56 acetylation peaks represent the enriched regions. The Y-axis represents the number of reads per million sequenced, note that each ChIP
experiment was plotted on a different scale on the Y-axis. Arrows indicate the direction of transcription. (B) Profiles from gene set enrichment
analysis. Left: HSA4920 Adipocytokine signaling pathway. Right: HSA04930 Type II Diabetes Mellitus. Genes were ranked based on the number of
acetylated sites per gene. Black lines represent genes with the specified annotation. The Y-axis represents the enrichment score (see [23]).
doi:10.1371/journal.pone.0019778.g004
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nuclei. The authors suggested that the hyperacetylation observed
may be related to a disruption of neuroendocrine regulation. In
our study, we observed widespread H3K56 acetylation in human
adipocytes; the degree of which is particularly significant in genes
related to the adipokine signaling and Type II Diabetes Mellitus
pathways. This gives rise to the possibility that H3K56, by means
of its acetylation status, regulates diverse endocrine functions in
both adipocytes and neurons. Profiling H3K56 and other histone
acetylation sites in adipocytes in different metabolic conditions (for
example, comparing insulin sensitive and insulin resistant
adipocytes) and identifying the acetylase/deacetylases that are
responsible for the modification will be an important step towards
understanding the chromatin acetylation dynamics in normal and
diseased states.
Our study is the first genome-wide H3K56 acetylation profile
and binding location analysis for E2F4, HSF-1 and C/EBPa in
human adipocytes. It provides a rich resource for future studies of
the transcriptional regulation in human adipocytes.
Materials and Methods
Culturing human mesenchymal stem cell-derived
adipocytes
Human mesenchymal stem cells (hMSC) at passage 2 (PT2501)
were purchased from Lonza (Walkersville, MD), who obtained the
cells from the bone marrow withdrawn from the posterior iliac
crest of the pelvic bone of normal volunteers. Cells were plated in
T-175 flasks at a density of 5000 cells/cm
2 in MSC growth media
(MSC-GM). For expansion of hMSC, cells were grown in T-175
flasks but prior to reaching confluence, cells were detached by
trypsinization and replated at a density of 5000 cells/cm
2. This
process was repeated until the cells reach passage 4 to 7, when we
induced the cells to differentiate: upon reaching confluence, the
MSC-GM was removed and fresh adipogenic differentiation
media (ADM; PT3004) containing 120 pM insulin, dexametha-
sone, IBMX, and indomethacin was added. The cultures were
maintained in ADM for 14 days with media changes every 3–4
days. On day 14, the media was changed to adipogenic
maintenance media (AMM) containing 120 pM insulin
(PT4119A). On day 19, the adipocyte cultures were fixed by
adding 20 ml serum free DMEM containing 1/10 volume of
cross-linking solution (11% formaldehyde, 50 mM HEPES,
100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA) for 10 minutes
at room temperature. The formaldehyde was neutralized by the
addition of 1 ml of 2.5 M glycine. Cultures were then rinsed twice
in PBS (one quickly, one 5–10 minute) and then treated with 5 ml
of Accutase solution (SCR005, Millipore) for 5 min at 37uC. Cells
were then scraped and pooled into 50 ml tubes. Up to 30 T-175
flasks of cells were used for each adipocyte preparation.
Human MSC-derived adipocytes purification
The adipocyte suspension from up to 10 T-175 flasks was
pipetted up and down several times to enhance separation and
then centrifuged for 25 minutes at 15uC at 3500 rpm. Due to their
low density, the adipocytes floated at the surface while the denser
non-adipocytes formed a pellet. The relatively pure adipocyte
fraction formed a white layer (anti-pellet) at the meniscus and was
transferred to a second tube by pipetting carefully. PBS was added
to bring the volume to 50 ml and the tube was centrifuged for 5
minutes. The buoyant cell mass was harvested in the same
manner, washed in PBS again and spun for 5 minutes. The PBS
underneath the cells was carefully decanted and the cell mass (anti-
pellet) was flash-frozen in liquid nitrogen. Each T-175 flask
routinely yields ,4 million cells, of which.50% (2 million) are
adipocytes. All experiments were done using cells with passage
number less than 8.
Cellomics high content image analysis
Human bone marrow mesenchymal stem cells were induced to
differentiate in 96-well plates as described above for 19 days and
fixedwith4%paraformaldehydesolutionfor30minutes.Theplates
were washed with PBS, permeabilized with 0.1% Triton-X for 30
minutes and stained with PPARc antibody (Cell Signaling
Technologies, 10 mg/ml) overnight. Plates were washed with PBS,
then DAPI (1 mg/ml), Nile red (1 mg/ml) and secondary Alexa-647
antibody(Invitrogen)wereaddedandincubatedfor2 hoursatroom
temperature. Plates were washed with PBS, sealed and analyzed on
a Cellomics Arrayscan. 100 fields per well of a 96-well plate were
analyzed. DAPI, a nuclear stain, was used to count the number of
nuclei per field. Nile red, a lipid droplet specific stain, was used to
quantify the percent of differentiated adipocytes per field. Alexa 647
was used to quantify PPARc expression and subcellular location.
Chromatin Immunoprecipitation and high-throughput
sequencing
Chromatin immunoprecipitation was done as described [17],
with modifications. 5 ug of each antibody (listed in Table S2) was
incubated with preblocked Dyanbead Protein A (Invitrogen
100.02D) overnight. The specificity of the antibodies was
previously described [6,12,26,27]. Human adipocytes were lysed
in cold lysis buffer (20 mM HEPES, 0.25 M sucrose, 3 mM
MgCl-2, 0.2% NP-40, 3 mM b-mercaptoethanol, 0.4 mM PMSF
and protease inhibitor), dounced using a hand-held homogenizer
for 20 strokes and incubated for 10 minutes at 4uC. Cells were
then spun down and resuspended in ChIP SDS buffer (50 mM
HEPES, 1% SDS, 10 mM EDTA and protease inhibitor). The cell
lysate was sonicated using a Misonix Sonicator 3000 for 12 cycles;
each cycle consisted of a 20-second pulse and a 1-minute pause.
The sonicated chromatin was then diluted with ChIP dilution IP
buffer (50 mM HEPES, 155 mM NaCl, 1.1% Triton-X, 0.11%
sodium deoxycholate, 1 mM PMSF and protease inhibitor) and
incubated with the antibody-coupled beads overnight. The beads
were then washed five times with RIPA wash buffer and one time
with TBS. The chromatin was eluted in ChIP elution buffer,
reverse-crosslinked at 65uC overnight, treated with RNase and
Proteinase K. The DNA was extracted with phenol-chloroform,
precipitated with ethanol, purified and subjected to sequencing
preparation using the Illumina sample preparation protocol.
Sequencing was done using the Illumina Genome Analyzer II.
Figure 5. Correlation in binding locations of C/EBPa, E2F4 and H3K56 acetylation. (A) DUSP1 is bound by multiple transcription factors
and also has multiple H3K56 acetylation enrichment regions. The rectangular boxes below the peaks represent the enriched regions. (B) Histogram
showing the correlation coefficients representing similarity between the relative locations of C/EBPa and E2F4 enrichment signal (left) and E2F4 and
H3K56 acetylation enrichment signal (right). (C) Heatmaps showing the intensity of bound regions centered on E2F4 peaks, indicated by an asterisk.
Each row in the heatmap represents each binding region, which has been divided into fifteen bins of one hundred base pairs. The color scale
indicates the Z score of the number of reads in each bin. The immunoprecipitated proteins are E2F4 (left), C/EBPa (middle) and H3K56 acetylation
(right).
doi:10.1371/journal.pone.0019778.g005
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ChIP experiments for H3K56 acetylation, E2F4, HSF-1 and C/
EBPa were performed as described above using separate adipocyte
preparations. We chose 21 positive loci and 2 negative loci to
verify the ChIP-seq peaks by qPCR. Enrichment was measured
using SYBR Green I master mix in the Light Cycler 480
instrument (Roche) by comparing the percent input of the ChIP
sample versus that of the IgG control sample, performed in
triplicate using standard t-test. Only amplified products with a CP
(crossing point) number of less than 33 were considered as positive.
Primers sequences used for qPCR analysis were designed by
oligo7, blasted against hg18 and a melt curve was generated for
each reaction to make sure that only one product was amplified.
Primer sequences are in Table S6.
ChIP-seq data processing and peak calling algorithm
Unique sequences from each ChIP-seq experiment were
extended 200 base pairs in a strand specific manner and allocated
to 25-basepair bins across the genome. Peaks calling was done as
described [28]: genomic bins containing statistically significant
ChIP-seq enrichment were identified by comparison to a Poisson
background model, using a p-value threshold of 10
29. The
minimum number of counts in a genomic bin required for each
sample to meet this threshold was calculated; they are 12, 8, 10
and 8 for H3K56 acetylation, C/EBPa, E2F4 and HSF-1
respectively. Bins that are within 200 bases of each other were
combined to form regions. In order to take into account of the
non-random nature of the background reads, an empirical
background model was obtained from a mock IP experiment
using IgG. We required that enriched regions have more than
three-fold greater ChIP-seq density in the specific IP sample as
compared with the non-specific IgG sample, normalized for the
total number of reads. The raw data are deposited in GEO with
accession number GSE24326.
Gene expression analysis
Frozen cells were resuspended in Qiagen RLT buffer and total
RNA isolated using the Qiagen RNeasy Kit. RNA was submitted
to GeneLogic for cRNA preparation using the Affymetrix
Genechip IVT Kit and hybridization to Affymetrix U133 Plus
2.0 microarrays. Expression raw data were processed using the
Robust Multichip Average (RMA) R package in Bioconductor
(http://bioconductor.org). During this processing, only the perfect
match (PM) probe data were used; the mismatch (MM) probes
were not used. The RMA processing consisted of background
correction, quantile normalization to remove deleterious system-
atic effects between arrays and median polish used to estimate
expression values and an additive model fit on log2(PM) values.
The raw data are deposited in GEO with accession number
GSE24422. All data is MIAME (Minimum Information about a
Microarray Experiment) compliant.
Gene ontology and pathway analysis
Gene Ontology analysis was done using PANTHER [29] and
DAVID [30,31]. Redundant GO categories were removed. All p-
values presented were corrected for multiple hypothesis testing.
Motif discovery method
Over-represented transcription factor motifs were identified in
each experiment using THEME [19]. THEME uses principled
statistical methods to test hypotheses about the binding specificity of
the immunoprecipitated protein. Hypotheses are position weight
matrix representations of DNA sequence motifs in the TRANSFAC
and JASPAR database. They were evaluated based on their cross-
validation error, which represents their ability to predict which
sequences from a held-out test set were bound by the protein and
which were not. Each hypothesis was either accepted or rejected
based on a p-value, which was derived from comparing its
predictive value to those of motifs derived by applying the same
algorithm to randomly selected sequences for 25 times.
Computation of correlation between ChIP-seq peaks
We identified regions of 1500 base pairs that contained binding
sites peaks in the E2F4, C/EBPa and H3K56 acetylation data sets,
where each region is centered around the E2F4 peak. For each
enriched region, we computed three vectors, each represents the
number of reads in one of the three datasets in 100-basepair bin,
normalized by the total number of reads sequenced. These vectors
were used to compute the correlation coefficient in figure 5B and
are clustered and visualized as heatmaps in figure 5C.
Supporting Information
Figure S1 H3K56 acetylation enrichment is lower
immediately before transcription start sites. The top
panel shows the normalized enrichment level of H3K56
acetylation with respect to transcription start sites from 210
kilobases to +10 kilobases in 100-basepair genomic bins. The
normalized enrichment level in each genomic bin was computed
by merging the reads across all genes, divided by the maximum
number of reads in any genomic bin. The bottom panel is same as
the top one with higher resolution around 21 kilobase to +1
kilobase with respect to transcription start sites.
(TIF)
Figure S2 ChIP-qPCR verification of binding sites
identified by ChIP-seq experiments. Positive regions
identified by ChIP-seq are indicated with *; positive regions verified
by ChIP-qPCR are indicated with #. FP represents false positive
and FN represents false negative. Y-axis shows percent of input and
X-axis shows the particular ChIP experiment. (A) Selected H3K56
acetylation regions identified by ChIP-seq. (B) Selected bound
regions identified by E2F4 ChIP-seq. (C) Selected bound regions
identified by HSF-1ChIP-seq.(D)Selected bound regions identified
by C/EBPa ChIP-seq. (E) Selected bound regions identified by
multiple ChIP-seq experiments. (F) Negative control.
(TIF)
Figure S3 C/EBPa binds to adiponectin promoter and
intronic enhancer. Profile of C/EBPa binding sites along the
adiponectin gene as shown on UCSC genome browser. Back-
ground represents the mock IgG experiment reads. Rectangular
boxes below the C/EBPa peaks represent the enriched regions.
The Y-axis represents the number of reads per million sequenced.
The arrow indicates direction of transcription. Notice that there is
a strong C/EBPa binding site upstream of the adiponectin
transcription start site, a site that lies exactly at the transcription
start site and another site (circle in red) that lies in the middle of
the first intron, which has previously been identified as an intronic
enhancer.
(TIF)
Table S1 High content image analysis results of the
differentiation efficiency of replicates of 6 MSC-derived
adipocyte cultures.
(XLSX)
Table S2 Antibodies used in this study.
(DOCX)
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enriched for each ChIP-seq experiment.
(DOCX)
Table S4 Number and percentage of genes with H3K56
acetylation and also bound by a particular transcription
factor.
(DOC)
Table S5 List of genes that have H3K56 acetylation and
also bound by at least one transcription factor.
(XLSX)
Table S6 Primer sequences used in this study.
(XLSX)
Table S7 Gene set enrichment results with a family-
wise error rate of less than 0.05.
(DOCX)
Table S8 Gene ontology (GO) categories associated with
the bound/enriched genes for each ChIP-seq experi-
ment.
(DOCX)
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